Vimarsana
Biggest News Aggregation in the World

Page 8 - Eligo Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eligo Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eligo Bioscience Today - Breaking & Trending Today

Sanofi's Origimm takeover acquires skin microbiome-targeting candidate for acne vaccine - Vimarsana News

Sanofi's Origimm takeover acquires skin microbiome-targeting candidate for acne vaccine

Sanofi is to acquire Origimm Biotechnology in a move that gives the pharma giants a candidate to develop a first-in-class acne vaccine, which targets the skin microbiome and bacterial antigens that cause the skin condition.

Sanofi's Origimm takeover acquires skin microbiome-targeting candidate for acne vaccine - Vimarsana News

Sanofi's Origimm takeover acquires skin microbiome-targeting candidate for acne vaccine

Sanofi is to acquire Origimm Biotechnology in a move that gives the pharma giants a candidate to develop a first-in-class acne vaccine, which targets the skin microbiome and bacterial antigens that cause the skin condition.

Eligo Bioscience Announces Successful Outcome in US Patent Interference against SNIPR Biome on CRISPR-Cas antimicrobials - Vimarsana News

Eligo Bioscience Announces Successful Outcome in US Patent Interference against SNIPR Biome on CRISPR-Cas antimicrobials

/PRNewswire/ -- Eligo Bioscience today announced that the US Patent and Trademark Office (USPTO) has issued on Nov 19, 2021, a decision and a judgement...

Eligo Bioscience Announces Successful Outcome in US Patent Interference against SNIPR Biome on CRISPR-Cas antimicrobials - Vimarsana News

Eligo Bioscience Announces Successful Outcome in US Patent Interference against SNIPR Biome on CRISPR-Cas antimicrobials

/PRNewswire/ -- Eligo Bioscience today announced that the US Patent and Trademark Office (USPTO) has issued on Nov 19, 2021, a decision and a judgement...

GSK and Viome expand microbiome-based cancer therapeutics deal - Vimarsana News

GSK and Viome expand microbiome-based cancer therapeutics deal

GlaxoSmithKline (GSK) are to expand on an existing collaboration with Viome that looks into links between the gut microbiome and certain cancers.